Tretinoin tocoferil

Drug Profile

Tretinoin tocoferil

Alternative Names: L 300; N 021; N 021G; Olcenon; Tocoretinate

Latest Information Update: 20 Oct 2009

Price : $50

At a glance

  • Originator Nisshin Pharma
  • Class Antiulcers; Retinoids; Small molecules
  • Mechanism of Action Antioxidants; Free radical scavengers; Retinoic acid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Skin ulcer
  • Suspended Peptic ulcer

Most Recent Events

  • 16 Oct 2009 Wyeth has been acquired by Pfizer
  • 11 Sep 2000 Suspended-Phase Unspecified in Peptic ulcer in Japan (PO)
  • 17 Jul 1998 No-Development-Reported for Peptic ulcer in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top